Literature DB >> 22477831

Aluminum in pediatric parenteral nutrition products: measured versus labeled content.

Robert L Poole, Kevin P Pieroni, Shabnam Gaskari, Tessa K Dixon, Kt Park, John A Kerner.   

Abstract

OBJECTIVE: Aluminum is a contaminant in all parenteral nutrition solutions. Manufacturers currently label these products with the maximum aluminum content at the time of expiry, but there are no published data to establish the actual measured concentration of aluminum in parenteral nutrition solution products prior to being compounded in the clinical setting. This investigation assessed quantitative aluminum content of products commonly used in the formulation of parenteral nutrition solutions. The objective of this study is to determine the best products to be used when compounding parenteral nutrition solutions (i.e., those with the least amount of aluminum contamination).
METHODS: All products available in the United States from all manufacturers used in the production of parenteral nutrition solutions were identified and collected. Three lots were collected for each identified product. Samples were quantitatively analyzed by Mayo Laboratories. These measured concentrations were then compared to the manufacturers' labeled concentration.
RESULTS: Large lot-to-lot and manufacturer-to-manufacturer differences were noted for all products. Measured aluminum concentrations were less than manufacturer-labeled values for all products.
CONCLUSIONS: The actual aluminum concentrations of all the parenteral nutrition solutions were significantly less than the aluminum content based on manufacturers' labels. These findings indicate that 1) the manufacturers should label their products with actual aluminum content at the time of product release rather than at the time of expiry, 2) that there are manufacturers whose products provide significantly less aluminum contamination than others, and 3) pharmacists can select products with the lowest amounts of aluminum contamination and reduce the aluminum exposure in their patients.

Entities:  

Year:  2011        PMID: 22477831      PMCID: PMC3208446          DOI: 10.5863/1551-6776-16.2.92

Source DB:  PubMed          Journal:  J Pediatr Pharmacol Ther        ISSN: 1551-6776


  20 in total

1.  Polyethylene vials of calcium gluconate reduce aluminum contamination of TPN.

Authors:  O R Frey; L Maier
Journal:  Ann Pharmacother       Date:  2000-06       Impact factor: 3.154

2.  Nutritional aspects of aluminium toxicity.

Authors:  G L Klein
Journal:  Nutr Res Rev       Date:  1990-01       Impact factor: 7.800

3.  Aluminum in large and small volume parenterals used in total parenteral nutrition: response to the Food and Drug Administration notice of proposed rule by the North American Society for Pediatric Gastroenterology and Nutrition.

Authors:  G L Klein; A M Leichtner; M B Heyman
Journal:  J Pediatr Gastroenterol Nutr       Date:  1998-10       Impact factor: 2.839

4.  Aluminum contamination of neonatal parenteral nutrient solutions and additives.

Authors:  J F Mouser; A H Wu; V C Herson
Journal:  Am J Health Syst Pharm       Date:  1998-05-15       Impact factor: 2.637

5.  Aluminum toxicity.

Authors:  E Gilbert-Barness; L A Barness; J Wolff; C Harding
Journal:  Arch Pediatr Adolesc Med       Date:  1998-05

6.  Aluminum neurotoxicity in preterm infants receiving intravenous-feeding solutions.

Authors:  N J Bishop; R Morley; J P Day; A Lucas
Journal:  N Engl J Med       Date:  1997-05-29       Impact factor: 91.245

7.  Influence of the glass packing on the contamination of pharmaceutical products by aluminium. Part II: amino acids for parenteral nutrition.

Authors:  D Bohrer; P C do Nascimento; R Binotto; R Carlesso
Journal:  J Trace Elem Med Biol       Date:  2001       Impact factor: 3.849

8.  Aluminum toxicity in infants and children. American Academy of Pediatrics, Committee on Nutrition.

Authors: 
Journal:  Pediatrics       Date:  1996-03       Impact factor: 7.124

9.  Influence of the glass packing on the contamination of pharmaceutical products by aluminium. Part III: Interaction container-chemicals during the heating for sterilisation.

Authors:  Denise Bohrer; Paulo Cícero do Nascimento; Regina Binotto; Emilene Becker
Journal:  J Trace Elem Med Biol       Date:  2003       Impact factor: 3.849

10.  Aluminum content of parenteral nutrition in neonates: measured versus calculated levels.

Authors:  Robert L Poole; Linda Schiff; Susan R Hintz; Allison Wong; Nicol Mackenzie; John A Kerner
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-02       Impact factor: 2.839

View more
  4 in total

Review 1.  Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts.

Authors:  Calvin C Willhite; Nataliya A Karyakina; Robert A Yokel; Nagarajkumar Yenugadhati; Thomas M Wisniewski; Ian M F Arnold; Franco Momoli; Daniel Krewski
Journal:  Crit Rev Toxicol       Date:  2014-10       Impact factor: 5.635

2.  Prevention and treatment of intestinal failure-associated liver disease in children.

Authors:  Bram P Raphael; Christopher Duggan
Journal:  Semin Liver Dis       Date:  2013-02-08       Impact factor: 6.115

3.  A Filtration System That Greatly Reduces Aluminum in Calcium Gluconate Injection, USP Used to Prepare Parenteral Nutrition Solutions.

Authors:  Robert A Yokel; Wesley R Harris; Christopher D Spilling; Vasiliy P Abramov; Jason M Lone; Robert J Kuhn
Journal:  J Pediatr Pharmacol Ther       Date:  2014-07

4.  Aluminum exposure in neonatal patients using the least contaminated parenteral nutrition solution products.

Authors:  Robert L Poole; Kevin P Pieroni; Shabnam Gaskari; Tessa Dixon; John A Kerner
Journal:  Nutrients       Date:  2012-11-02       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.